Abstract
The effect of the dopamine agonist, bromocriptine, and the dopamine antagonist, metoclopramide, on glucose tolerance was examined in maturity onset diabetics and normal subjects. After bromocriptine there was a lowered fasting blood glucose and improved glucose tolerance in the diabetics. The controls showed an initial improvement in glucose tolerance. A reduction in insulin levels and a marked fall in plasma prolactin was observed in all subjects. Growth hormone concentrations were low and unaffected in the diabetics, and there was an inconsistent rise in the normals. After metoclopramide there was some impairment in glucose tolerance in the normal subjects, but this was not significant in the diabetics. There was also a marked prolactin release in all subjects, but no significant effect on insulin or growth hormone. It is concluded that bromocriptine lowers the blood glucose and improves glucose tolerance in maturity onset diabetics. This action may be the result of the lowered prolactin which occurred without a concomitant rise in growth hormone.
References
Feb 28, 1976·Lancet·G Teasdale
May 1, 1977·Acta diabetologica latina·A GnudiM G Cavazzini
Apr 1, 1977·Diabetologia·R LandgrafP C Scriba
Sep 1, 1977·The Journal of Clinical Endocrinology and Metabolism·P D WoolfR Campbell
Feb 8, 1975·British Medical Journal·M O ThornerG M Besser
Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·F CamanniG M Molinatti
Nov 1, 1972·The Journal of Clinical Endocrinology and Metabolism·E Del PozoH Friesen
Sep 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M RozencweigC Robyn
May 1, 1972·Gut·T E BynumE D Jacobson
Citations
Oct 11, 2011·Cardiology in Review·Guy Valiquette
Oct 28, 2010·Diabetes, Obesity & Metabolism·R I G HoltC J Bailey
Dec 24, 2013·Biochimica Et Biophysica Acta·Thomas BouckenoogheAnne Vambergue
Mar 15, 1992·Experientia·A H MeierW C Lovell
Jan 5, 2001·Expert Opinion on Investigational Drugs·A H CincottaM Cincotta
Jan 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Felicitas Lopez VicchiDamasia Becu-Villalobos
Jun 28, 2011·Lancet·Abd A TahraniAnthony H Barnett
May 1, 1985·Clinical Endocrinology·G SassolasF Borson
May 1, 1985·Clinical Endocrinology·D G JohnstonD Cook
Feb 1, 1983·Clinical Endocrinology·I N ScobieA C Maccuish
May 20, 2014·Journal of Diabetes and Its Complications·Tance SonnierCourtney M Peterson
Jun 25, 2016·Nature Reviews. Endocrinology·Abd A TahraniClifford J Bailey
Oct 28, 2010·The Annals of Pharmacotherapy·Jessica L KerrKatherine A Petkewicz
Nov 22, 2018·Endocrinology·Isadora C FurigoJose Donato
Jan 1, 1985·Postgraduate Medical Journal·A D MooradianR B Shafer
Jun 28, 2019·Internal Medicine·Tamami OshigeMasatoshi Nomura
Dec 29, 2012·Molecular Biology Reports·Rajib Mukherjee, Jong Won Yun
Feb 25, 1985·Life Sciences·H F MohamedI el-Wakkad